2016 annual financial data
Ernexa Therapeutics 2016 Net margin
Direct answer
Net margin was -13.1%.
Operating income was -2,278,000 USD and net income was -2,923,000 USD.
Operating cash flow was 23,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,312,000 USD
- Operating income
- -2,278,000 USD
- Net income
- -2,923,000 USD
- Operating cash flow
- 23,000 USD